Preoperative Arterial Embolization Before Oncologic Esophagectomy as a Technique for Ischemic Gastric Conditioning

Preoperative Arterial Embolization Before Oncologic Esophagectomy as a Technique for Ischemic Gastric Conditioning : a Retrospective Monocentric Comparative Study

This retrospective monocentric comparative study aims to assess the efficacy of preoperative ischemic conditioning, in preventing anastomotic leakage in esophageal cancer surgery. Two groups were included : a surgery-alone group (control group) and a PreopAE group (study group) treated with an embolization procedure before esophagectomy. Collected data included patient characteristics, embolization procedure details, surgical outcomes, and postoperative complications.

The primary outcome was the efficacy of preoperative ischemic conditioning in preventing anastomotic leakage, assessed through CT scans. Secondary outcomes included analyzing safety of ischemic gastric conditioning, hypertrophy of the gastroepiploic artery in embolized patients and comparing hospital stay length and postoperative mortality.

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Saint-Priest-en-Jarez, France, 42270
        • CHU de Saint-Etienne
        • Sub-Investigator:
          • Sylvain Grange, MD
        • Principal Investigator:
          • Rémi Grange, MD
        • Contact:
          • Rémi Grange, MD
        • Sub-Investigator:
          • Zoé Sahut, resident

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Patients with non-metastatic oesophageal cancer, eligible for curative surgery by oesophagectomy.

Description

Inclusion Criteria:

  • All patients older than 18 years with an indication for surgical esophagectomy with cervical anastomosis using the Lewis Santy technique or three stages approach.

Exclusion Criteria:

  • Esophagectomy for ischemic or caustic oesophagitis, and patients lost for follow-up.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Control group
Esophagectomy alone

Collecting data from the medical record:

  • Gastroepiploic artery diameter before and after ischaemic preconditioning
  • Postoperative mortality
  • Complications related to embolisation and surgery
  • Length of stay in intensive care unit and total length of hospital stay
Study Group
Preoperative ischemic conditioning before esophagectomy

Collecting data from the medical record:

  • Gastroepiploic artery diameter before and after ischaemic preconditioning
  • Postoperative mortality
  • Complications related to embolisation and surgery
  • Length of stay in intensive care unit and total length of hospital stay

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurement of the effectiveness of preoperative ischaemic conditioning in reducing anastomotic leakage in patients undergoing oesophagectomy.
Time Frame: Day : 90
Radiological confirmation by thoracoabdominal CT scan with oral contrast showing dehiscence of the oesophagastric anastomosis will be sought.
Day : 90

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurement of the effectiveness of preoperative ischaemic conditioning in reducing anastomotic leakage in patients undergoing oesophagectomy.
Time Frame: Day : 90
Dehiscence confirmed by the surgeon during a repeat operation will be sought.
Day : 90
Measurement of the effectiveness of preoperative ischaemic conditioning in reducing anastomotic leakage in patients undergoing oesophagectomy.
Time Frame: Day : 90
Endoscopic confirmation of an anastomotic leak will be sought.
Day : 90
Safety of ischemic gastric conditioning
Time Frame: Day : 90
Safety of ischaemic gastric filling will be analysed on the basis of imaging and data recordings.
Day : 90
Hypertrophy of the gastroepiploic artery
Time Frame: Day : 90
Hypertrophy of the gastroepiploic artery in embolized patients will be analysed on the basis of imaging and data recordings.
Day : 90
Comparing hospital stay length
Time Frame: Day : 90
Hospital stay length will be analysed on the basis of data recordings.
Day : 90
Comparing postoperative mortality
Time Frame: Day : 90
Postoperative mortality will be analysed on the basis of data recordings.
Day : 90

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rémi GRANGE, MD, CHU de Saint-Etienne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2024

Primary Completion (Estimated)

December 1, 2025

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

March 4, 2024

First Submitted That Met QC Criteria

March 8, 2024

First Posted (Actual)

March 15, 2024

Study Record Updates

Last Update Posted (Actual)

March 15, 2024

Last Update Submitted That Met QC Criteria

March 8, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • IRBN032024/CHUSTE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Esophageal Cancer

Clinical Trials on Collecting data from the medical record

3
Subscribe